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Abstract
Objective: Hyperchromatic crowded groups (HCG), a term first introduced into the cytology
literature by DeMay in 1995, are commonly observed in Pap tests and may rarely be associated
with serious but difficult to interpret lesions. In this study, we specifically defined HCG as dark
crowded cell groups with more than 15 cells which can be identified at 10× screening magnification.
Methods: We evaluated consecutive liquid-based (Surepath) Pap tests from 601 women (age 17–
74 years, mean age 29.4 yrs) and observed HCG in 477 cases. In all 477 HCG cases, Pap tests were
found to be satisfactory and to contain an endocervical sample. HCG were easily detectible at 10×
screening magnification (size up to 400 um, mean 239.5 um) and ranged from 1 to 50 (mean 19.5)
per Pap slide.
Results: HCG predominantly represented 3-Dimensional groups of endocervical cells with some
nuclear overlap (379/477 – 79%), reactive endocervical cells with relatively prominent nucleoli and
some nuclear crowding (29/477 – 6%), clusters of inflammatory cells (25/477 – 5.2%), parabasal
cells (22/477 – 4.6%), endometrial cells (1/477 – 0.2%). Epithelial cell abnormalities (ECA) were
present in only 21 of 477 cases (4.6%). 18 of 21 women with HCG-associated ECA were less than
40 years old; only 3 were =/> 40 years. HCG-associated final abnormal Pap test interpretations
were as follows: ASCUS (6/21 – 28%), LSIL (12/21 – 57%), ASC-H (2/21 – 9.5%), and HSIL/CIN2-
3 (3/21 – 14%). The association of HCG with ECA was statistically significant (p = 0.0174. chi-
square test). In patients with ECA, biopsy results were available in 10 cases, and 4 cases of biopsy-
proven CIN2/3 were detected. Among these four cases, HCG in the Pap tests, in retrospect
represented the lesional high grade cells in three cases (one HSIL case and two ASC-H cases).
Interestingly, none of the 124 cases without HCG were found to have an epithelial cell abnormality.
Conclusion: We conclude: a. HCG are observed in a high proportion of cervical smears. b. In the
vast majority of cases, HCG are benign. c. ECA were only observed in cases with HCG. This
observation is consistent with the hypothesis that the presence of HCG in Pap tests most often
represents adequate sampling of the transformation zone, thus increasing the chances of detecting
an epithelial cell abnormality. d. Only a few cases with HCG were associated with a serious ECA,
but careful scrutiny of all HCG appears warranted to avoid the potential diagnostic pitfall of a
significant false negative interpretation.
Published: 22 January 2007
CytoJournal 2007, 4:2 doi:10.1186/1742-6413-4-2
Received: 6 September 2006
Accepted: 22 January 2007
This article is available from: http://www.cytojournal.com/content/4/1/2
© 2007 Chivukula et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.CytoJournal 2007, 4:2 http://www.cytojournal.com/content/4/1/2
Page 2 of 8
(page number not for citation purposes)
Background
The term hyperchromatic crowded groups (HCG) was
introduced into the cytology literature in DeMay's 1995
first edition of The Art and Science of Cytopathology [1].
DeMay noted that "although hyperchromatic crowded
groups are usually benign and include such entities as
endometrial cells and severe atrophy; they can also be the
general cytologic appearance of a variety of serious
lesions." He first noticed the possible significance of these
groups when examining a large series of Pap tests inter-
preted as "negative" from a single patient who ultimately
developed cervical cancer and initiated litigation [2].
Glandular cells tend to present much more frequently as
HCG than squamous cells. Endocervical cells, endome-
trial cells, tubal metaplasia, and cone artifact are just some
of the many benign glandular cell groups which may
present as HCG, whereas atrophy is the most common
benign cause of HCG associated with squamous epithe-
lium [1,3]. Although relatively uncommon, epithelial cell
abnormalities (ECA) may also present as HCG. Significant
lesions such as carcinoma-in-situ (CIS), squamous cell
carcinoma, adenocarcinoma in situ (AIS), endocervical
adenocarcinoma, small cell carcinoma, endometrial ade-
nocarcinoma, and even metastatic carcinoma may present
in part or entirely as HCG [1,3,4].
There is currently limited literature as how to precisely dif-
ferentiate benign HCG from precancerous or malignant
HCG [1,3,4]. The difficulty of cytologic interpretation
may on occasion represent a highly clinically significant
diagnostic pitfall. Aside from seminal publications by
DeMay, reports specifically analyzing the cytologic evalu-
ation of HCG are still uncommon [5-7]. We undertook
this study to further evaluate this challenge and to charac-
terize some of the cytologic patterns associated with HCG.
Materials and methods
We define HCG in this study as groups of darkly staining
cells which measured 100 µm or more and which were
easily detectable at 10× screening magnification. Consec-
utive Pap tests from 601 women from 17 to 74 years old
(mean 29) were selected for the study. All specimens were
collected with the Cervex-Brush® in SurePath collection
medium™. Of the 601 consecutive Pap tests, 38 had no
endocervical cells or T zone metaplastic cells and 10 were
unsatisfactory. The Pap slides were evaluated for the pres-
ence of HCG. Cytomorphologic features such as the size
of the cellular groups, background, cohesiveness of the
cell clusters, shape of the cell groups, presence of feather-
ing or other cell group border features were noted. The
individual size and shape of the cells, N/C ratio, cyto-
plasm, chromatin, nuclear contour, and presence of
nucleoli were also noted.
Results
HCG were present in 477 of 601 cases (79.4%) and absent
in 124 cases (20.6%). HCG were benign in over 95% of
cases (Table 1). Benign HCG included 3-Dimensional
groups of endocervical cells with some nuclear overlap
(379/477 – 79%) (Figure 1), reactive endocervical cells
with relatively prominent nucleoli and some nuclear
crowding (29/477 – 6%) (Figure 2), groups of inflamma-
tory cells (25/477 – 5.2%) (Figure 3), endometrial cells
(1/477 – 0.2%) (Figure 4) and parabasal cells (15
atrophic and 7 postpartum) (22/477 – 4.6%) (Figure 5).
Twenty one of 477 HCG cases (4.6%) were associated
with epithelial cell abnormalities (ECA). 18 of 21 women
with HCG-associated ECA were below 40 years of age;
only 3 were =/> 40 years (Figure 7). The final abnormal
cytological interpretations/results in these abnormal cases
were as follows: ASCUS (6/21 – 28%), ASC-H (2/21 –
9.5%), LSIL (12/21 – 57%), and HSIL (3/21 – 14%). The
association of HCG with ECA was statistically significant
(p = 0.0174, chi-square test). In the group with ECA, fol-
low-up cervical biopsy results were available in 10 cases.
One LSIL case with non-lesional benign HCG was found
subsequently on follow-up cervical biopsy to harbor a
high grade squamous intraepithelial lesion (CIN II)
(Table 2). A total of four biopsy proven CIN2/3 cases were
associated with HCG (Figure 6). Among these four cases,
HCG in the smear actually represented the atypical
lesional cells in three cases (one HSIL cytology and two
ASC-H cytology cases). Although the total number of
HCG-associated abnormal cases in this series is small, an
interesting and unexpected finding was that in none of the
124 cases with satisfactory sampling of transformation
zone but without HCG showed any epithelial cell abnor-
mality.
Discussion
Hyperchromatic crowded groups, termed HCG by DeMay
[1], are a frequent occurrence in Pap Tests. Benign glandu-
lar cells HCG are seen far more frequently than either
abnormal glandular cell HCG or squamous cell HCG,
normal or abnormal in routine Pap Tests. In this study,
endocervical cells were by far the most common cause of
benign HCG cell groups. We report here for the first time
the significant association of HCG with endocervical sam-
pling. All cases with HCG were consistent with optimum
sampling of the transformation zone. We also report for
the first time a significant increase in detection of epithe-
lial cell abnormalities (ECA) in Pap tests with HCG as
opposed to Pap tests without HCG. We conclude that
these observations are best explained by the hypothesis
that the presence of HCG in Pap tests most often repre-
sents adequate sampling of the transformation zone, thus
increasing the chances of detecting an epithelial cell
abnormality.CytoJournal 2007, 4:2 http://www.cytojournal.com/content/4/1/2
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Endocervical sampling has been significantly enhanced
with the advent of the endocervical brush [8], even as
coincidentally increased sampling of the lower uterine
segment (LUS) [9,10], endocervical tubal metaplasia
(TME) [11,12], brush-induced atypia (brush effect) [13],
reparative endocervical changes [14], cone artifact [15],
cervical endometriosis [16], and microglandular hyper-
plasia [17,18] have added to the complex list of benign
endocervical glandular HCG that must be distinguished
from neoplastic lesions. The detection of TME, approxi-
mately 31% in cone or hysterectomy specimens [19], has
undoubtedly risen in recent decades as a result of the
improved ability of the cytobrush to sample the upper
endocervix. TME may present as flat sheets or 3D HCG
with a finely granular chromatin, dark nuclei, absent
nucleoli. The presence of cilia and peg cells are very helpful. In
the absence of ciliated cells, the reporting of atypical glan-
dular cells on the Pap tests is a common outcome [11,12].
Benign endometrial cells often present in the Pap tests as
HCG. The cells are small, and crowded; the nuclei may be
degenerate and hyperchromatic. Mitotic figures are not
typically seen in exfoliated cells but may be seen in
directly sampled cells [3]. Benign endometrial cell HCG
spontaneously shed in menstrual smears may especially
show concerning degenerative chromatin changes, but the
cell groups typically lack features commonly described in
neoplasia [20], especially the more pronounced nuclear
atypia seen at least in higher grade endometrial cancers
[21]. Tubal metaplasia of the endometrium and other forms of
endometrial metaplasia, also termed epithelial cytoplasmic
change [22], have been much more frequently recognized
in endometrial surgical pathology specimens than in
cytology specimens. The relatively few cytologic descrip-
tions suggest that they may present as HCG and that their
accurate recognition can be a significant diagnostic chal-
lenge [23,24].
One of the most important abnormal glandular causes of
HCG is endocervical neoplasia, including both adenocarci-
noma in situ (AIS) and invasive adenocarcinoma [1,3].
Detection rates of AIS on Pap tests have risen with the
widespread use of endocervical brush sampling [25];
however, there are many benign conditions which can
mimic AIS [26]. Additional features such as marked
hyperchromasia, altered nuclear polarity, increased N/C
Reactive endocervical cells with relatively prominent nucleoli  and some nuclear crowding (100×) Figure 2
Reactive endocervical cells with relatively prominent nucleoli 
and some nuclear crowding (100×).
Reactive endocervical cells
Table 1: Association of HCG with benign groups
Groups identified #/out of %
3-Dimensional groups of endocervical cells with some nuclear overlap 379/477 79.4
Reactive endocervical cells with relatively prominent nucleoli and some nuclear crowding 29/477 6.0
Endometrial cells 1/477 0.2
Parabasal cells (15 atrophic and 7 postpartum) 22/477 4.6
Clusters of inflammatory cells 25/477 5.2
Total 456/477 95.4
3-Dimensional groups of endocervical cells with some  nuclear overlap, (40×) Figure 1
3-Dimensional groups of endocervical cells with some 
nuclear overlap, (40×).CytoJournal 2007, 4:2 http://www.cytojournal.com/content/4/1/2
Page 4 of 8
(page number not for citation purposes)
ratio, and associated single cells have been described as
helpful diagnostic features [26,27]. An increasingly com-
mon endometrioid variant of AIS has a distinct small cell
pattern and may be an especially common cause of false
negative interpretations as it can be difficult to distinguish
from cells sampled from LUS [28]. Presence of endome-
trial glands and stroma in the cells derived from LUS are
helpful cytologic features to distinguish LUS from AIS.
Endometrial adenocarcinoma can also present as HCG.
Nuclear enlargement and presence of nucleoli are helpful
cytomorphologic features (28). Some studies have
reported enhanced accurate recognition with liquid-based
cytology [30-33].
Parabasal cells associated with an atrophic cellular pattern
in postmenopausal or postpartum specimens are often
seen as syncytial aggregates of cells with small closely
packed parabasal cells with dark nuclei and scant cyto-
plasm. These may on occasion be difficult to distinguish
from CIS [34]. Maturation of the cells at the periphery of
the groups of parabasal cells is one clue which may help
to recognize the atrophic nature of the smear. A study by
Harris et al to evaluate the dense nuclei of HCG using dig-
ital measurements revealed that the atrophic groups had
significantly lower nuclear area (mean 0.4 µm) than HSIL
(mean 0.9 µm) [6]. In another recent study on the cyto-
morphologic spectrum of ASC-H from the authors' abora-
tories, it was noted that parabasal cell HCG often present as
small dark nuclei with variable cytoplasm and a moderate
N/C ratio. The chromatin is typically dark but not
clumped. These groups may be interpreted as ASC-H [35].
Recognition of this distinctive cytomorphologic pattern
and HPV DNA testing can be very helpful in establishing
the benign character of these cell groups [36].
The other most clinically significant differential diagnosis
with HCG is that of a high grade squamous intraepithelial
lesion (CIN2,3/CIS) with or without involvement of
endocervical glands. The cytomorphologic features of
HSIL include small dysplastic cells as compared to larger
cells of LSIL. HCG in this study never represented lesional
LSIL cells. Cells of HSIL usually occur as small single cells,
but when present as syncytial-like aggregates, the HCG
may be misinterpreted as other benign HCG. Close scru-
tiny under high-magnification is needed. Attention must
be given to features such as increased nuclear size and
hyperchromasia, fine-coarsely granular chromatin, and
irregular nuclear contours. Nucleoli are usually absent but
may be seen along the periphery of the groups, especially
when the dysplasia involves endocervical glands [37]. In
Parabasal cells, (100×) Figure 5
Parabasal cells, (100×).
Parabasal cells
Groups of inflammatory cells, (100×) Figure 3
Groups of inflammatory cells, (100×).
Endometrial cells, (100×) Figure 4
Endometrial cells, (100×).
Endometrial cellsCytoJournal 2007, 4:2 http://www.cytojournal.com/content/4/1/2
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Liquid based preparations, it has been observed that dis-
persed single dysplastic cells are more often seen than
sheets or syncytial groups [38]. The study of dense HCG
by Harris et al found that HSIL groups contained the high-
est nuclear area (mean-0.9 µm) as compared to invasive
squamous cell carcinoma (mean -0.8 µm) or endometrial
adenocarcinoma (mean – 0.64 µm) [6]. Interpretation of
HCG of HSIL may be challenging in conventional as well
as liquid based preparations. In a recent study from the
College of American Pathologists PAP Program, poorly
performing conventional smear and Thin-Prep HSIL cases
were compared. HCG were observed in both the prepara-
tions. The HSIL groups were often interpreted as glandular
lesions when there was rounding up of cells with small
nuclei and smooth contoured borders. On the other hand,
these cell groups were interpreted as squamous lesions
when elongated and large nuclei were present [38,39].
The distinction of CIS involving the endocervical glands
from AIS may impact management decisions. HCG may
be seen in both the groups. The cells of AIS show spin-
dling in the center with round to oval nuclei, peripheral
palisading, and pseudostratification at the edge [40].
In summary, HCG are observed in a high proportion in
cervical smears. Most of these cell groups turn out to be
benign. However, there is a small proportion of HCG
associated with serious abnormalities. The careful scrutiny
of HCG is mandatory, as such cell groups are common in
litigated cases alleged as interpretive false negatives [3]. A
number of different cytomorphologic features, discussed
above, can be utilized in distinguishing benign from high
grade precancerous or malignant HCG. The judicious use
of reflex HPV-DNA testing (34), p16INK4A or other immu-
nocytochemical stains such as ProEx C [42], and compu-
ter-assisted imaging employing DNA sensitive stains [43]
may aid interpretation of HCG-associated high grade
squamous and glandular intraepithelial lesions or malig-
nancy.
(A): HSIL (Pap Test) (100×); (B): Cervical intraepithelial neoplasia 2 (CIN2) on biopsy (40×) Figure 6
(A): HSIL (Pap Test) (100×); (B): Cervical intraepithelial neoplasia 2 (CIN2) on biopsy (40×).
HSIL- CIN 2
FIGURE-6B FIGURE-6ACytoJournal 2007, 4:2 http://www.cytojournal.com/content/4/1/2
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Table 2: Cyto-histo correlation of HCG representing HSIL




Relationship of HCGs with Epithelial abnormalities (ECA) Figure 7











*p= 0.0174 (Chi Square Test)
Epithelial Cell Abnormalities (ECA) were observed 
predominantly in smears showing hyperchromatic groups.
Relationship of HCGs with Epithelial Cell Abnormalities (ECA) CytoJournal 2007, 4:2 http://www.cytojournal.com/content/4/1/2
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